Study #2014-0616
PET/MR, PET/CT and Whole Body MR in Newly Diagnosed Acute Myeloid leukemia (AML)
MD Anderson Study Status
Enrolling
Treatment Agent
Gadolinium
Description
This pilot phase I trial studies how well positron emission tomography (PET)/magnetic resonance imaging (MRI), fludeoxyglucose F-18 (18F-FDG) PET/computed tomography (CT), and whole body MRI work in finding extramedullary myeloid leukemia in patients with newly diagnosed acute myeloid leukemia. Extramedullary myeloid leukemia is a type of cancer found outside of the bone marrow and can be hard to detect with routine bone marrow monitoring, such as bone marrow aspirations. Diagnostic procedures, such as PET/MRI, 18F-FDG PET/CT and whole body MRI, may help find and diagnose extramedullary myeloid leukemia in patients with newly diagnosed acute myeloid leukemia.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Acute Myeloid Leukemia, Acute Promyelocytic Leukemia With PML-RARA
Study phase:
Phase I
Physician name:
Dawid Schellingerhout
Department:
Diagnostic Radiology
For general questions about clinical trials:
1-866-402-0289
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.